| 25th Apr 2024 3:46 pm |
RNS |
Change of Name |
| 22nd Apr 2024 10:11 am |
RNS |
Holding(s) in Company |
| 11th Apr 2024 3:04 pm |
RNS |
Holding(s) in Company |
| 9th Apr 2024 7:00 am |
RNS |
Holding(s) in Company |
| 8th Apr 2024 4:03 pm |
RNS |
Holding(s) in Company |
| 5th Apr 2024 3:39 pm |
RNS |
Director/PDMR Shareholding |
| 5th Apr 2024 2:40 pm |
RNS |
Holding(s) in Company |
| 4th Apr 2024 1:59 pm |
RNS |
Result of General Meeting |
| 4th Apr 2024 7:00 am |
RNS |
Result of Retail Offer |
| 19th Mar 2024 5:03 pm |
RNS |
Retail Offer |
| 19th Mar 2024 5:00 pm |
RNS |
Acquisition, Fundraising and Change of Name |
| 27th Feb 2024 7:00 am |
RNS |
SFX-01 positive update in bowel cancer models |
| 19th Feb 2024 11:22 am |
RNS |
Positive update on SFX-01 in vitro GBM studies |
| 9th Feb 2024 11:01 am |
RNS |
Notice of Dispute lodged with Stalicla SA |
| 16th Jan 2024 3:07 pm |
RNS |
Series B Fund Raise by partner, Stalicla SA |
| 29th Dec 2023 11:29 am |
RNS |
Holding(s) in Company |
| 22nd Dec 2023 7:00 am |
RNS |
Directorate Changes |
| 13th Nov 2023 7:00 am |
RNS |
Upcoming conferences |
| 31st Oct 2023 7:00 am |
RNS |
Half-year Report |
| 26th Oct 2023 7:00 am |
RNS |
Erasmus Medical Center begins glioblastoma studies |
| 19th Oct 2023 2:26 pm |
RNS |
Authored Article Publication |
| 5th Sep 2023 7:00 am |
RNS |
Directorate Changes |
| 15th Aug 2023 7:00 am |
RNS |
Final Report from Phase 1b PK/PD study |
| 3rd Aug 2023 12:38 pm |
RNS |
Rule 17 Disclosure |
| 2nd Aug 2023 7:00 am |
RNS |
Return of rights to Sulforadex from Juvenescence |
| 21st Jul 2023 12:02 pm |
RNS |
Result of AGM |
| 27th Jun 2023 7:00 am |
RNS |
SFX-01 radiosensitisation effect confirmed in-vivo |
| 20th Jun 2023 1:59 pm |
RNS |
Notice of AGM & Posting of Annual Report |
| 19th Jun 2023 7:00 am |
RNS |
Grant Success for Glioblastoma studies |
| 7th Jun 2023 7:00 am |
RNS |
Final Results |
| 26th May 2023 11:00 am |
RNS |
Notice of Results |
| 22nd Mar 2023 7:00 am |
RNS |
Preliminary results from Phase 1b study |
| 16th Mar 2023 2:00 pm |
RNS |
Price Monitoring Extension |
| 16th Mar 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
| 16th Mar 2023 11:00 am |
RNS |
Price Monitoring Extension |
| 16th Mar 2023 7:00 am |
RNS |
Further evidence of radiosensitisation by SFX-01 |
| 13th Mar 2023 7:00 am |
RNS |
No exposure to Silicon Valley Bank |
| 25th Jan 2023 7:00 am |
RNS |
Clinical trial update |
| 14th Dec 2022 5:08 pm |
RNS |
Grant of Options - Director/PDMR Shareholding |
| 12th Dec 2022 11:54 am |
EQS |
Evgen Pharma 'cash runway in pretty good shape' |
